1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 2:Averages of NAA/Cr, mean isotropic ADC value, and mean FA value of control group and four patient groups
Group NAA/Cr P Isotropic ADC (×10−3 mm/2/s) P FA P Controls 1.31 ± 0.18 0.692 ± 0.014 0.38 ± 0.02 1 (0–2 mo) 1.28 ± 0.26 .77 0.696 ± 0.016 .06 0.38 ± 0.02 .91 2 (3–5 mo) 1.13 ± 0.10 .04 0.724 ± 0.060 <.01 0.34 ± 0.04 <.01 3 (6–9 mo) 1.23 ± 0.07 .26 0.687 ± 0.018 .52 0.39 ± 0.03 .57 4 (10–12 mo) 1.28 ± 0.09 .78 0.710 ± 0.007 .12 0.40 ± 0.03 .10
Note.—NAA/Cr indicates N-acetylaspartate to creatine ratio; ADC, apparent diffusion coefficient; FA, fractional anisotropy. Values are expressed as mean ± SD. P values were obtained by comparison between the values of each patient group versus those of the control group.